Зміст
Добірка наукової літератури з теми "Prostate – Cancer – Soins médicaux"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Prostate – Cancer – Soins médicaux".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Prostate – Cancer – Soins médicaux"
de Camargo, Júlia Drummond, Valéria Delponte, Adriana Zancheta Sousa Costa, and Regina Claudia da Silva Souza. "Survie des patients en oncologie traités par l’équipe de soins palliatifs d’un hôpital de São Paulo, au Brésil." Canadian Oncology Nursing Journal 32, no. 2 (April 21, 2022): 190–97. http://dx.doi.org/10.5737/23688076322190197.
Повний текст джерелаCalvo-Schimmel, Alejandra, S. Newman, K. Sterba, M. Mueller, C. Miaskowski, and S. Qanungo. "Besoins non satisfaits en soins de soutien chez les survivants du cancer de la prostate à un stade avancé : exploration par méthodes mixtes." Canadian Oncology Nursing Journal 32, no. 4 (October 24, 2022): 526–41. http://dx.doi.org/10.5737/23688076324526.
Повний текст джерелаSheikh-Wu, Sameena, Debbie Anglade, and Charles Downs. "Modèle de survie au cancer appliqué aux soins holistiques et à la recherche." Canadian Oncology Nursing Journal 33, no. 1 (January 31, 2023): 17–30. http://dx.doi.org/10.5737/2368807633117.
Повний текст джерелаPreti, Beatrice, Jasna Deluce, and Siddhartha Srivastava. "Type B Lactic Acidosis in a Solid-Tumour Malignancy Without Liver Metastases." Canadian Journal of General Internal Medicine 16, no. 2 (June 21, 2021): 38–42. http://dx.doi.org/10.22374/cjgim.v16i2.427.
Повний текст джерелаMc Brearty, Claudia, Laurie Bisaillon, Sophie Lauzier, and Josée Savard. "Peur de la récidive du cancer en contexte pandémique chez les femmes atteintes d'un cancer du sein." Psycause : revue scientifique étudiante de l'École de psychologie de l'Université Laval 13, no. 1 (September 2, 2023): 15–22. http://dx.doi.org/10.51656/psycause.v13i1.51849.
Повний текст джерелаNoveiri, Marzieh Jahani Sayad, Farshid Shamsaei, Masoud Khodaveisi, Zohreh Vanaki, and Lily Tapak. "Concept d’adaptation chez les conjoints de femmes iraniennes atteintes du cancer du sein : étude qualitative basée sur une approche phénoménologique." Canadian Oncology Nursing Journal 31, no. 3 (July 22, 2021): 322–29. http://dx.doi.org/10.5737/23688076313322329.
Повний текст джерелаDariane, Charles, Manon Baures, Julien Anract, Nicolas Barry Delongchamps, Jacques-Emmanuel Guidotti, and Vincent Goffin. "Progéniteurs luminaux prostatiques." médecine/sciences 39, no. 5 (May 2023): 429–36. http://dx.doi.org/10.1051/medsci/2023058.
Повний текст джерелаChabanol, Hedi, Olivier Huillard, Lucie Prin, Clémentine Villeminey, Aurélie Rondeau, Pascaline Boudou-Rouquette, Florence Astorg, et al. "Soins podologiques intégrés chez les patients atteints de cancer de prostate traités par docétaxel : faisabilité et résultats." Bulletin du Cancer 105, no. 12 (December 2018): 1173–82. http://dx.doi.org/10.1016/j.bulcan.2018.06.005.
Повний текст джерелаLehoux, Pascale, Myriam Hivon, and Julie Fattal. "Épistémologies civiles et institutionnalisation de trois technologies médicales controversées." Sociologie et sociétés 42, no. 2 (January 20, 2011): 231–64. http://dx.doi.org/10.7202/045363ar.
Повний текст джерелаAllard, Christopher, Paul Yip, Ivan Blasutig, Karen Hersey, and Neil Fleshner. "Does the reflexive measurement of free PSA have a role in a tertiary cancer centre?" Canadian Urological Association Journal 4, no. 5 (April 18, 2013): 317. http://dx.doi.org/10.5489/cuaj.902.
Повний текст джерелаДисертації з теми "Prostate – Cancer – Soins médicaux"
Brun, Thomas. "Développement de méthode dosimétrique et de quantification du volume cible par IRM multiparamétrique pour le traitement ultra-focal du cancer de la prostate en curiethérapie de grains liés d'iode-125 personnalisés." Electronic Thesis or Diss., Université de Toulouse (2023-....), 2024. http://www.theses.fr/2024TLSES071.
Повний текст джерелаThe conventional treatment of localized prostate cancer, the most common cancer in men, is based on whole-gland treatment approaches and drives a significant risk of adverse effects in terms of continence and sexuality. Currently, various treatment strategies include surgery, external beam radiotherapy, or brachytherapy. However, surgical specimens have shown that in a significant proportion of patients, the risk of cancer progression is associated with a single focus of undifferentiated cancer. Therefore, treating the primary index lesion would achieve both cancer control and preservation of quality of life. Although recent developments in imaging and biopsy technologies can outline the extent of the cancer, the challenge of focusing the required precision with the treatment agent remains a daunting task, and focal treatments proposed between active surveillance of low-risk Prostate Cancer and definitive treatment of aggressive forms are still options under assessment Indeed, focal treatments raise questions that are still imperfectly resolved for an optimal clinical implementation: How to precisely define the target volume? How to focus the therapeutic agent on this target? And finally, how to monitor the rest of the gland after treatment? The aim of this thesis project is to develop and evaluate the dosimetric feasibility of an experimental ultra-focal treatment for prostate cancer using iodine-125 seeds brachytherapy and to develop a quantification method for the precise definition of the primary tumor focus using multiparametric MRI (mpMRI) imaging. To achieve this, the number and activity of I-125 seeds used for conventional prostate brachytherapy are defined based on the volume of the entire gland (approximately 2 seeds/cc). By definition, ultra-focal brachytherapy targets complex-shaped and smaller volumes, prompting us to develop a dosimetric method for implanting multiple seeds with low activity. Secondly, the precision objective in seed delivery led us to implement the sequential use of three distinct imaging systems: mpMRI to inform on the position and volume of the target, 3D transrectal ultrasound to deliver a fiducial marker into the target leveraging non-rigid fusion with mpMRI, and a 2D biplanar ultrasound probe required for treatment planning and seed placement. Finally, the evaluation of treatment quality - that is, the dose delivered to the single target as opposed to the entire gland in conventional brachytherapy - was made possible by developing a quantification method based on the precise definition of the position of the target tumor volume to be treated from mpMRI data and compared to dosimetric data obtained for each patient in the study
Phung, Thi Thanh Tu. "Évaluation et modélisation de la qualité de vie des patients traités pour un cancer de la prostate." Thesis, Montpellier 1, 2011. http://www.theses.fr/2011MON1T016.
Повний текст джерелаTreatments for prostate cancer "PCa" are almost equivalent in terms of survival; however,they can provoke different side effects affecting quality of life "QoL" patients. It is thereforeessential to assess on one hand the QoL of patients newly diagnosed with PCa as wells asthose newly diagnosed with a recurrence of PCa to know the quality of life associated witheach kind of treatment is and on the other hand to evaluate their utility scores by the methodof “ Standard Gamble”. We conducted a prospectively cohort study of 305 patients treated forPCa in the departments of Hérault and Gard. The study found that QoL of patients wasdifferent according to treatment modalities. Patients in the group "prostatectomy" had moresexual dysfunction and urinary incontinence. Patients in the group “radiotherapy" had morebowel dysfunction and symptoms related to hormone treatment. Symptoms related tohormonal disorders of PCa, sexual dysfunction, insomnia, urinary incontinence, and the sumof co-morbidities are significant predictors of utility score
Chauvin, Pauline. "Evaluating health expenditures with cost-effectiveness analysis : foundations, methods and application to colorectal cancer mass screening." Rennes 1, 2011. http://www.theses.fr/2011REN1G011.
Повний текст джерелаThe on-going growth of medical expenditures in most countries has strengthened the interest for economic evaluations of health care programmes. This thesis questions the extent to which and how Cost-Effectiveness Analysis (CEA) can be used to evaluate health care expenditures. CEA is defined as the methodological approach valuing consequences of allocation of resources with non-monetary units. More specifically, it is used to assess alternative mass screening strategies for Colorectal Cancer (CRC) in France. Even though CEA is currently the reference in health care assessment, its theoretical foundations are not definitely settled. In the first part of this thesis, three potential normative frameworks for CEA are considered, namely welfare economics, the capability and extra-welfarist approaches. Then in a second part, the methodology enabling to properly use CEA is examined. Eventually, two CEAs are implemented to assess alternative mass screening strategies for CRC in France. The potential contribution of Computed Tomography Colonography (CTC) to CRC mass screening is considered. A Markov model is elaborated in order to compare CTC with guaiac and immunological fecal occult blood tests. The first test is currently used in France for the mass screening campaigns while the second one is likely to replace it
Maurel, Jean. "Apport des registres de cancer à l'évaluation des pratiques de soins en cancérologie : à propos du cancer colorectal." Caen, 1997. http://www.theses.fr/1997CAEN3097.
Повний текст джерелаTraoré, Sory. "Estimations non-paramétriques de coût médical et d'incidences d'événements cliniques : application à l'évaluation médico-économique d'un dépistage pré-thérapeutique des toxicités du 5-fluorouracile." Angers, 2010. http://tel.archives-ouvertes.fr/tel-00967957/fr/.
Повний текст джерелаThis thesis deals with non parametric estimation methods of medical cost and of incidences of clinical events that generate it. Such statistical analysis methods already exist but they are sometimes misused due to the bias induced by the data when encountering censorship, recurence of interest events, and competitive risks. The choice of a correct statistical method of estimation is generally an issue within such a context. In a first part, we have studied the statistical methods that are usually used but none was defined at a sufficient general level to take into account all the classical situations. So, in a second time, we have developped a "multi-state" framewok of non parametric approaches allowing to estimate both the medical cost and the incidences of the events that generate it when in presence of all these situations. The properties of the estimators, in terms of bias and asymptotic behavior have been then studied. Finally, all the methods that were studied and developped have been applied to a real case: the medical and economical evaluation of the pre-treatment screening of the toxicities for the 5-fluorouracile that has been set up by the research teams of the Laboratoire d'Oncopharmacologie and INSERM U892 of the Centre Paul Papin d'Angers. This study has showed that this pre-treatment screening could lead to a significant reduction of the major and lethal toxicities which takes place during the first two cycles of the treatment that uses the 5-FU. Moreover, the supplementary cost that it induces could be significantly inferior to the cost of the toxicities that it helps to avoid, whatever type of economical study is considered
Lejeune, Catherine. "Analyse coût-efficacité du dépistage de masse du cancer colorectal en France : utilisation d'un modèle de simulation." Dijon, 2003. http://www.theses.fr/2003DIJOMU04.
Повний текст джерелаBarbaret, Cécile. "Détresse financière en phase palliative chez les patients atteints de cancer : vers une approche structurée des coûts de la fin de vie Financial distress in patients with advanced cancer Inequalities in financial distress, symptoms and quality of life among patients with advanced cancer in France and the United States of America The association between palliative care team follow-up and aggressiveness of cancer care near the end of life. Research Protocol on Early Palliative Care in patients with acute leukaemia after one relapse." Thesis, Université Grenoble Alpes (ComUE), 2019. https://thares.univ-grenoble-alpes.fr/2019GREAS022.pdf.
Повний текст джерелаConcerns about costs of the palliative phase in patients with cancer has emerged. Beyond usual measures to control health expenses other ways involving clinical, teaching and research might impact costs of the palliative phase and health expenses.Methods:Association between financial distress and lower quality of life was highlighted. In order to improve patients’ quality of life, focusing on costs and financial distress seems necessary. Other studies especially one concerning aggressive cancer care near the end of life were made. Those criteria could be one source of health expenses and alteration of quality of life.Discussion: Collaboration, anticipation, quality of professionals training programs and palliative care research development are all possible solutions which could lead to decrease health expenses. In literature no study focusing on all type of cost during the palliative phase was made. All this work leads to a new research protocol concerning palliative phase costs among patients with cancer.Conclusion: Understanding specific cancer expenses for patients and their families is undoubtedly important for quality of life. Concerning a more global approach, health consumptions and quality of collaboration are possible ways to improve quality of life while respecting the individual and the collectivity. Death is inevitable but our way to die is not. Clinics, research and teaching are the three axes to focus on
Méthy, Nicolas. "Identification et évaluation des critères de substitution en cancérologie digestive." Dijon, 2009. http://www.theses.fr/2009DIJOMU04.
Повний текст джерелаOverall survival is the gold standard endpoint in phase III cancer clinical trials. Its evaluation may require long follow-up. The use of surrogate endpoints allows to reduce trial duration. A surrogate endpoint is expected to predict treatment effect on the clinical endpoint of interest. Two statistical methods have been proposed to evaluate a surrogate endpoint. The first one consists in estimating the proportion of treatment effect explained by the surrogate. The second one is a meta-analytical approach consisting in calculating the correlation between treatment effects on each endpoint. To date, few surrogates have been validated in digestive oncology. A questionnaires survey among clinicians and methodologists allowed to draw up an ordered list of potential surrogates, candidate for statistical evaluations. Best rated endpoints were disease-free survival and progression-free survival in association or not with quality of life. In neo-adjuvant rectal cancer trials, pathological parameters are early indicators of treatment effect. Their surrogacy was evaluated in the FFCD 9203 trial. Single-trial analyses did not validate these parameters as surrogate endpoints for overall survival or local control. Pooled analyses with the EORTC 22921 trial confirmed these results. Preliminary analyses using the meta-analytical technique have suggested that progression-free survival could be surrogate for overall survival
Borie, Frédéric. "Prise en charge et surveillance du cancer colo-rectal : analyses médico-économiques et décisionnelles." Lyon 1, 2002. http://www.theses.fr/2002LYO10262.
Повний текст джерелаMolinier, Laurent. "Les analyses économiques dans la prise en charge des cancers : évaluation et modélisation des coûts application au cancer bronchopulmonaire." Toulouse 3, 2007. http://www.theses.fr/2007TOU30054.
Повний текст джерелаIn France, approximately 28 000 cases of lung cancer are diagnosed each year. This work provides new information on the evaluation and the modelling of costs of this pathology. We summarized the state of the knowledge and the reflections currently led in the fields of the economic evaluation of healthcare programs and their modelling. This aim of this work was to evaluate the costs of managing patients with lung cancer in France. Markov chains built on the different management phases were developed. This type of modelling constitutes an inexpensive tool for simulation and very instructive in its educations, particularly for understanding of the consequences of this disease. This thesis also aimed at analyzing the methodological characteristics of the studies estimating the cost of this pathology. A supplementary effort is to be realized in the field of the methodological validation
Книги з теми "Prostate – Cancer – Soins médicaux"
Joseph, Lipscomb, Gotay Carolyn C. 1951-, and Snyder Claire 1973-, eds. Outcomes assessment in cancer. Cambridge, UK: Cambridge University Press, 2005.
Знайти повний текст джерела1966-, Gould Judy, Nelson Jennifer J. 1972-, and Keller-Olaman Sue, eds. Cancer on the margins: Method and meaning in participatory research. Toronto: University of Toronto Press, 2009.
Знайти повний текст джерелаHeld-Warmkessel, Jeanne. Contemporary Issues in Prostate Cancer. Jones and Bartlett Publishers International, 2000.
Знайти повний текст джерелаHeld-Warmkessel, Jeanne. Contemporary Issues in Prostate Cancer: A Nursing Perspective (Jones and Bartlett Series in Oncology). Jones & Bartlett Publishers, 2000.
Знайти повний текст джерелаHeld-Warmkessel, Jeanne. Contemporary Issues in Prostate Cancer: A Nursing Perspective, Second Edition. 2nd ed. Jones & Bartlett Pub, 2005.
Знайти повний текст джерелаSnyder, Claire, Joseph Lipscomb, and Carolyn C. Gotay. Outcomes Assessment in Cancer. Cambridge University Press, 2005.
Знайти повний текст джерелаSnyder, Claire, Joseph Lipscomb, and Carolyn C. Gotay. Outcomes Assessment in Cancer: Measures, Methods and Applications. Cambridge University Press, 2005.
Знайти повний текст джерелаSnyder, Claire, Joseph Lipscomb, and Carolyn C. Gotay. Outcomes Assessment in Cancer: Measures, Methods and Applications. Cambridge University Press, 2004.
Знайти повний текст джерелаSnyder, Claire, Joseph Lipscomb, and Carolyn C. Gotay. Outcomes Assessment in Cancer: Measures, Methods and Applications. Cambridge University Press, 2009.
Знайти повний текст джерелаSnyder, Claire, Joseph Lipscomb, and Carolyn C. Gotay. Outcomes Assessment in Cancer: Measures, Methods and Applications. University of Cambridge ESOL Examinations, 2011.
Знайти повний текст джерела